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INTRODUCTION
Because of improvements in the fi  eld of radiology as well 
as increased awareness, cystic neoplasms are increasingly 
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diagnosed. Other factors include the optimization of 
the timing of contrast agent injection and the imaging 
during the appropriate vascular phase after contrast agent 
injection. Cystic tumors of the pancreas accounts for 
about 10-15% of all cystic pancreatic lesions (1) and are 
composed of a variety of neoplasms with a wide range of 
malignant potential. 
Ductal adenocarcinoma is the most common of pancreatic 
neoplasms, accounting for 90% (2). Although the tumors are 
predominantly solid, cystlike features (cystic degeneration, 
retention cysts, and attached pseudocysts) were found 
at histologic analysis in 8% of ductal adenocarcinomas 
(3-6). Moreover, pancreatic ductal adenocarcinomas with 
cystic features (PDAC) are sometimes radiographically Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 188
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intratumoral cystic degeneration or necrosis, retention cysts 
induced by ductal obstruction, and attached pseudocysts 
(6, 8). As such, intraductal papillary-mucinous neoplasms 
(IPMN), mucinous cystadenocarcinomas, and other solid 
neoplasms sometimes undergo cystic changes and leads 
to the results being confused with PDAC radiographically 
and causes diffi  culty in differentiation. In view of all these 
entities requiring surgical resection, their preoperative 
differentiation may not be important in a clinical setting. 
In addition, if the communication between a peripherally 
based cystic pancreatic lesion and the ductal system can 
be established at imaging, the diagnosis of a side branch 
intraductal papillary mucinous neoplasm can be made (13, 
14). As a result, all these cases were excluded from the 
study. Finally, 88 patients were available for analysis, and 
these patients constituted our study population.
There were 26 patients with SCN (M:F = 7:19; age 
range, 29-70 years; mean age, 53 years). The masses 
were detected incidentally (n = 12) or with symptoms (n 
= 14) such as abdominal pain, abdominal distention or 
fever. A total of 20 patients with MCN (M:F = 7:13; age 
range, 18-77 years; mean age, 45 years). The lesions were 
detected because of abdominal pain, abdominal distention 
or jaundice (n = 16), or by incidental detection (n = 4). 
Only one of the patients with SCN and MCN respectively 
had a history of pancreatitis, whereas there were a total 
of 23 patients with a pseudocyst (16 men; age range, 30-
54 years; mean age, 44 years). Of the 23 patients, 21 had 
a history of pancreatitis. All patients were symptomatic 
(abdominal pain, n = 19; abdominal distention, n = 15) 
except for one, who was detected incidentally. Finally, there 
were 19 patients with PDAC (M:F = 8:11; age range, 42-
76 years; mean age, 61 years). Three of these lesions were 
incidentally found. The other 16 patients were symptomatic 
with nausea, emesis, weight loss, and jaundice, while four 
patients had a history of pancreatitis. Elevated tumor 
markers and blood sugar were found in nine patients.
CT Protocols
Different imaging protocols and equipment were used 
during the 6-year study period. Helical CT was performed 
with multi-detector row unit (16 or 64 detector rows) (GE 
LightSpeed; GE Medical Systems, Milwaukee, WI) in all 
patients. For routine abdominal CT scanning, 80-120 mL 
of nonionic contrast material (1.5 mL/kg) was injected at 
a rate of 2.0-3.0 mL/sec, and images were acquired at a 5 
mm section thickness after a 60-65 second delay. The fi  eld 
similar to some other cystic pancreatic lesions (2, 7, 8), 
including pancreatic serous cystadenoma (SCN), mucinous 
cystadenoma (MCN), pseudocyst, and so on. Serous 
cystadenoma are benign tumors, and in asymptomatic 
patients, do not require surgical excision. Pseudocysts 
represent the majority of cystic lesions and require different 
management, whereas most mucinous cystadenomas have 
malignant potential that warrants surgery but has a better 
prognosis than that of ductal adenocarcinomas (9, 10). 
Hence, accurate preoperative characterization of the lesions 
aids in prognostication and guides therapeutic decision 
making.
The role of the pancreatic cyst biopsy is debated. A 
particular concern is that the biopsy of a malignant fl  uid-
containing lesion may lead to leakage of the fl  uid from 
the cyst, hence spreading malignant cells. Moreover, a 
histological analysis of needle aspirates and chemical 
analysis of cyst fl  uid produces a questionable diagnostic 
yield. Hence, a non-invasive method of assessment is a 
signifi  cant clinical need. Multi-detector row computed 
tomography (MDCT) allows thin-section scanning of the 
pancreas and has become the preferred imaging modality for 
both the initial detection and characterization of pancreatic 
cysts (11, 12). But until now, no systematic investigation 
about radiographic appearances of PDAC has been reported.
Thus, the purpose of our study was to compare the 
CT appearances of pancreatic ductal adenocarcinoma 
with cystic features, of serous cystadenomas, mucinous 
cystadenoma, and of pseudocysts by reviewing the cases of 
a relatively large number of patients to determine if there 
are CT fi  ndings that may assist in the differential diagnosis.
MATERIALS AND METHODS
Institutional Review Board approval was obtained for 
this retrospective study and informed patient consent was 
not required. Patients whose medical and imaging data had 
been entered into our electronic radiology database from 
January 1, 2003 through October 31, 2009 were identifi  ed 
by means of a search for the term “pancreatic cyst” among 
the dictated CT examination reports. One hundred seventy-
six subjects were identifi  ed. Our pathology database was 
then used to determine whether a resection or aspiration 
of the cystic lesion had been performed. The patients 
who had got SCN, MCN, pseudocyst and PDAC on CT were 
included in the study. PDAC could be defi  ned as pancreatic 
ductal adenocarcinoma with cyst-like features such as Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 189
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of view was adjusted according to the size of the patient, 
while 32 patients received conventional scanning (16 on 16 
detector rows, 16 on 64 rows).
In patients with known or suspected to have a pancreatic 
lesion, a dedicated pancreatic CT angiography was used 
as either the initial or the follow-up study modality. After 
nonenhanced CT acquisitions in the liver and pancreas were 
performed, 80-120 mL of nonionic contrast material (1.5 
mL/kg) was injected at a rate of 2.5-3 mL/sec, and two 
acquisitions were performed. Pancreatic phase imaging was 
performed 40 seconds after contrast material injection by 
obtaining 3.75 mm or larger sections through the pancreas. 
Portal venous phase imaging with 3.75 mm thick sections 
followed at 65 seconds after contrast material injection. 
The reconstruction was performed in the pancreatic phase 
and the portal phase (section thickness, 2.5 mm; pitch, 
1.25). A total of 56 patients accepted the CT angiography 
operations (20 on 16 detector rows, 36 on 64 rows).
Image Analysis
The CT images were retrospectively reviewed by consensus 
between two radiologists (more than 10 years experience), 
who were aware of the diagnosis of the cystic pancreatic 
lesion but were blinded to the specifi  c diagnosis and clinical 
information. The number, size, location (head, neck, body 
or tail, diffuse), lesion contour (round or ovoid, lobulated 
or irregular), content (homogeneous, heterogeneous), and 
the morphologic features of the cysts such as the presence 
or absence of calcifi  cations, septa, or mural nodules on CT 
images, were recorded. “Lobulation” was defi  ned as the 
presence of rounded contours that could not be described 
as the borders of the same circle. “Irregular” was defi  ned 
as the mass or lesion not having clear dimensions that can 
be measured. The wall of the cyst was considered to be 
thick if it was more than 2 mm in diameter for at least 25% 
of the lesion circumference. The presence or absence of 
enhancement of the wall was identifi  ed on images obtained 
after contrast enhancement (12). 
Subjective visual criteria were used in place of region-
of-interest measurements. The common bile duct was 
considered abnormally dilated if the diameter was more 
than 6 mm (12); whereas, the main pancreatic duct 
was considered abnormally dilated if the diameter was 
more than 3 mm at the pancreatic head and 2 mm in 
the body and tail. The presence and distribution of 
pancreatic intraductal calcifi  cations (defi  ned as areas of 
hyperattenuation on nonenhanced images) were recorded. 
Peripancreatic abnormalities, including lymphadenopathy, 
vascular involvement, peripancreatic fat infi  ltration, and 
metastasis were noted. Peripancreatic lymphadenopathy 
was diagnosed when ovoid or round extravisceral masses 
were identifi  ed that had short-axis diameters of 10 mm or 
more and attenuation less than or equal to that of skeletal 
muscle. The peripancreatic adipose tissue was considered 
infi  ltrated if visually perceptible increased attenuation 
relative to that of subcutaneous fat was present.
Histopathologic Analysis
Color slides of the cut surface of the resected gross 
specimen or the paraffi  n-embedded tissue section were 
reviewed by an experienced pathologist. Enzyme levels, 
biochemical markers, immunohistochemical markers, and 
tumor markers were measured in cyst fl  uids. The maximal 
serum reference values for the normal range for amylase, 
CA199, CA125, carcinoembryonic antigen (CEA) and CA 
72-4 were < 5000 U/L, < 37 U/mL, < 35 U/mL, < 10 ng/mL 
(5 μg/L), and < 40 U/mL, respectively. 
From each case, one or two tissue blocks were analyzed 
immunohistochemically by using the primary antisera (MUC1, 
MUC2, MUC5AC, MUC6, p53). Cytologic examination was 
performed in all cases. Cuboidal epithelial cells containing 
cytoplasmic glycogen were characteristic of serous 
cystadenoma. Epithelial cells with cytoplasmic mucin led 
to the diagnosis of mucinous cystadenoma. The presence 
of acute infl  ammation and histiocytes was suggestive 
of a pseudocyst. The epithelial lining of these cysts was 
generally positive for MUC5AC, and CEA, MUC1, MUC6, 
or p53 were considered to be ductal adenocarcinomas 
with cystic changes (6). The combination of the typical 
features of the biochemical analysis, tumor markers, 
immunohistochemical markers, and cytologic analysis was 
considered suffi  cient to establish a specifi  c diagnosis.
Statistical Analysis
Differences in numbers between PDAC and the other three 
groups were compared by using the Fisher’s exact test. A 
p value less than 0.05 was considered to be statistically 
signifi  cant difference. The sensitivity and specifi  city values 
of the CT criteria were calculated.
RESULTS
Histopathologic Findings
Eighty-two patients underwent lesion resections, while Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 190
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the remaining six patients accepted a cyst fl  uid analysis. 
Twenty-four of the 26 patients with SCN underwent surgical 
resections. For the two remaining patients, a cyst fl  uid 
analysis demonstrated low tumor marker levels. Of the 20 
patients with mucinous cystadenoma, 19 of the diagnoses 
were based on resections and histopathologic confi  rmations, 
while the one remaining diagnosis was based on a cyst 
fl  uid analysis. A pancreatic resection was performed in 21 
of the 23 patients with a pseudocyst, and a histopathologic 
evaluation demonstrated the cystic lesion without lining 
epithelium. A cyst fl  uid analysis was performed in the 
two remaining patients with pseudocyst, and the analysis 
demonstrated high amylase levels (> 5000 U/L), abundant 
acute infl  ammation, and absence of epithelial cells. 
Pancreatic resections were performed in 18 of the 
19 patients with PDAC. The remaining one received 
chemotherapy because of metastasis. A histopathologic 
evaluation demonstrated a solid mass containing cystic 
lesions with or without lining epithelium which was 
generally positive for MUC5AC and CEA, MUC1, MUC6, or 
Table 1. CT Features in 88 Cystic Pancreatic Lesions
CT Features
Type
PDAC (n = 19) SCN (n = 26)  P1 MCN (n = 20)  P2 Pseudocyst  P3
Tumor location
† … 0.026 < 0.001
Head 11 10 4 2
Neck 0 4 0 0
Body or tail 8 12 16 11
Diffuse 0 0 0 10
Tumor contour
† < 0.001 0.003 < 0.01
Round or ovoid 3 12 13 15
Lobulated 1 9 1 1
Irregular 15 5 6 7
Cyst type
† … < 0.001 < 0.0001
Unilocular 3 9 10 21
Oligocystic 0 7 5 0
Polycystic 16 10 5 2
Daughter cyst in wall of main cyst 4 5 … 5  … 0  …
Contents
† 0.002 … < 0.001
Homogeneous 2 15 5 15
Heterogeneous 17 11 15 8
Septa
† 0.02 … < 0.0001
Central stellate 0 5 0 0
Linear or curvilinear 18 15 19 8
Absent 1 6 1 15
Mural nodules
† 18  5 < 0.001 16  … 5 < 0.0001
Localized thickening
† 18 11 < 0.001 9  … 7 < 0.0001
Wall calcifi  cation 4 6  … 6  … 0 …
Wall enhancement 14 22  … 19  … 12 …
Proximal atrophy
† 10 2 0.001 15 … 7 …
Pancreatic intraductal calcifi  cations 0 3  … 0  … 2 …
Note.— 
†CT features with statistical signifi  cance (p < 0.05). All compared with pancreatic ductal adenocarcinom with cystic 
features. Data are number of patients. MCN = mucinous cystadenoma, PDAC = pancreatic ductal adenocarcinom with cystic 
features, SCN = serous cystadenoma, … = not signifi  cantKorean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 191
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p53. 
Imaging Findings
The average size of PDAC (4.3 cm; size range, 1.5 to 7.5 
cm) was signifi  cantly smaller than a pseudocyst (9.9 cm; 
size range, 3.3-16.5 cm), but not different from SCN (3.1 
cm; size range, 1.5 to 10 cm) or MCN (mean, 6.6 cm; size 
range, 2.5 to 15 cm).
Tables 1 and 2 summarized the different imaging 
features observed in patients with PDAC, SCN, MCN, and a 
pseudocyst. The location of PDAC had no specifi  city and was 
signifi  cantly difference when compared to SCN. However, a 
statistical difference did exist for the comparison with MCN, 
which predominantly involved in the body and tail of the 
pancreas (16 of 20) (p < 0.05). Many pseudocysts (10 of 
23) occurred diffusely, which differed from PDAC (p < 0.001). 
The contour of SCN, MCN, and pseudocyst was mainly round 
or ovoid, which was signifi  cantly different from that of 
PDAC, and irregular (specifi  city of 74% for the diagnosis 
of PDAC) (p < 0.01). Further more, the lobulated contour 
was predominantly observed in SCN (9 of 26). The cystic 
type was divided into solitary, oligocystic or polycystic. 
The cystic type of PDAC was mainly multiple (16 of 19), 
similar to that of SCN (10 of 26) (p > 0.05), but different 
from MCN and a pseudocyst (p < 0.05). Because the cystic 
type of the latter two was mainly solitary. This gave a 
75% specifi  city for the diagnosis of PDAC. The content 
of cysts in PDAC and MCN was mainly heterogeneous, 
which was signifi  cantly different with SCN (p < 0.05) and 
pseudocyst (p < 0.001). The linear or curvilinear features 
could be observed in most patients with PDAC (18 of 19) 
(Fig. 1), similar to SCN (15 of 26), and MCN (19 of 20) and 
conversely to pseudocysts (8 of 23). The central stellate 
was observed exclusively in SCN (5 of 26). Moreover, the 
mural nodules and localized thickening of the wall were 
predominantly observed in patients with PDAC (Fig. 2), or 
for patients who showed a statistically signifi  cant difference 
compared to patients with SCN (p < 0.001) and pseudocysts 
(p < 0.0001), but showed a similarities for patients with 
MCN, which yielded a specifi  city of 62% and 61% for PDAC 
respectively. Proximal atrophy could often be observed 
in patients with PDAC (10 of 19), MCN (15 of 20) and a 
pseudocyst (7 of 23), except for patients with SCN (2 of 
26). The dilation of the biliary system and main pancreatic 
duct for PDAC showed a statistically signifi  cant difference 
compared to cases of MCN and pseudocysts (p < 0.05), but 
was not statistically signifi  cance when compared to SCN. 
This result yielded a specifi  city of 81% for the diagnosis 
of PDAC. Lymphadenopathy was observed in patients with 
PDAC and MCN, but not for patients with SCN (p < 0.05) or 
a pseudocyst (p < 0.05). The presence of peripancreatic fat 
Table 2. Other CT Features in 88 Cystic Pancreatic Lesions
Other CT Features PDAC (n = 19) SCN (n = 26)  P1 MCN (n = 20)  P2 Pseudocyst  P3
Dilatation of intrahepatic bile duct
† 8 4 … 2 0.031 0 < 0.001
Dilatation of common bile duct 8 7 …  5 … 0 < 0.001
Dilatation of main pancreatic duct
† 13 10 … 3 0.001 0 <  0.001
Lymphadenopathy
† 5 0 < 0.05 3 … 0 < 0.05
Peripancreatic fat infi  ltration
† 11 4 0.004 5 0.053 9 …
Vascular or peripheral tissues  
  involvement
† 14 3 < 0.001 5 0.004 10 …
Note.— 
†CT features with statistical signifi  cance (p < 0.05). All compared with pancreatic ductal adenocarcinom with cystic 
features. Data are number of patients. MCN = mucinous cystadenoma, PDAC = pancreatic ductal adenocarcinom with cystic 
features, SCN = serous cystadenoma, … = not signifi  cant
Fig. 1. Transverse CT scan obtained in 62-year-old man with 
pancreatic ductal adenocarcinoma with cystic features. 
Image was obtained after intravenous injection of contrast material 
demonstrated irregular multicystic lesion (long arrow) in head of 
pancreas. Wall is thick and enhancing on this contrast-enhanced 
image. Note septum (short arrow).Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 192
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infi  ltration and vascular or peripheral tissue involvement 
was observed in many patients with PDAC, which is similar 
to a pseudocyst, but signifi  cantly different from SCN (p < 
0.05) and MCN (p < 0.05), which led to a specifi  city of 74% 
for the diagnosis of PDAC.
Table 3 summarized the sensitivity and specifi  city values 
for the diagnosis of pancreatic ductal adenocarcinoma with 
cystic features. The imaging features of irregular contour, 
multiple cysts, mural nodes, localized thickening, dilatation 
of main pancreatic duct, peripancreatic fat infi  ltration, and 
vascular or peripheral tissue involvement may be useful for 
the diagnosis of PDAC with a relatively high sensitivity 
(> 50%) and specifi  city (> 50%). In particular, the 
sensitivity of mural nodes and localized thickening could 
be as high as 95%. A combination of the formal four CT 
fi  ndings could have 79% sensitivity and 75% specifi  city 
for the diagnosis of PDAC. The other features such as 
homogeneity of the lesion, presence of septa, proximal 
atrophy, lymphadenopathy, and dilatation of the common 
bile duct, were not helpful for lesion characterization.
Our study results suggest that CT fi  ndings, which 
include irregular contour, multiple cysts, mural nodes, 
localized thickening, as well as the dilatation of the 
main pancreatic duct, peripancreatic fat infi  ltration, and 
vascular or peripheral tissue involvement, were helpful for 
the characterization of PDAC, especially the former four 
features.
DISCUSSION
Ductal adenocarcinoma is the most common (15) and 
most lethal tumor of the pancreas, with a 5-year survival 
rate of less than 3%. The growth pattern of these tumors is 
usually infi  ltrative and results in the invasion of adjacent 
vasculature. Although the tumors are predominantly solid, 
they occasionally also have an associated cystic component 
or may undergo degeneration and can mimic a cystic 
neoplasm at imaging. However, many radiologists believed 
that the pancreatic ductal adenocarcinomas with cystic 
features are rare (2, 7), these cyst-like features (cystic 
degeneration, retention cysts, and attached pseudocysts) 
have been reported by many pathological studies (3, 
6, 8, 16, 17). They thought the pancreatic ductal 
adenocarcinomas and their variants with cystic features 
are neither rare, nor do they form a uniform group (6), and 
account for 7% of all cases on cystic neoplasms and lesions 
of the pancreas (16). However, the study results about the 
image fi  ndings of PDAC cannot be validated without further 
study to increase the sample size.   
The imaging features of pancreatic adenocarcinomas are 
AB
Fig. 2. Transverse CT scans obtained in 62-year-old man with pancreatic ductal adenocarcinoma with cystic features. 
A. Image obtained without intravenous contrast material demonstrates round cystic lesion in tail of pancreas. Wall of lesion was localized and 
found to be thick (arrow). B. Image obtained after intravenous injection of contrast material reveals enhancement of wall (short arrow). Note 
varicose veins of spleen (long arrow).
Table 3. Sensitivity and Specifi  city Values for CT Findings 
for Pancreatic Ductal Adenocarcinoma with Cystic Features 
Findings
Sensitivity 
(%)
Specifi  city 
(%)
Irregular contour 79 (15/19) 74 (51/69)
Multiple cysts  84 (16/19) 75 (52/69)
Mural nodes 95 (18/19) 62 (43/69)
Localized thickening 95 (18/19) 61 (42/69)
Dilatation of main pancreatic 
  duct
68 (13/19) 81 (56/69)
Peripancreatic fat infi  ltration 58 (11/19) 74 (51/69)
Vascular or peripheral tissues 
  involvement
74 (14/19) 74 (51/69)
Note.— Data in parentheses correspond to number of patients. Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 193
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well described in the literature. The poorly vascularized, 
infi  ltrative soft-tissue lesion shows delayed enhancement 
and causes ductal obstruction at an early stage of its 
development. Complex cystic areas representing adjacent 
pseudocysts, internal tumor necrosis, or side-branch 
ductal obstruction often may be seen within or adjacent 
to the primary soft-tissue lesion (2). Sahani et al. (7) 
believed that adenocarcinomas with an associated cystic 
component or are undergoing degeneration can mimic a 
cystic neoplasm at imaging. The intratumoral cystic lesions 
of PDACs on MRI reported by Yoon SE et al, were classifi  ed 
as either neoplastic mucin cysts with smooth margins 
and eccentric locations or cystic necroses with irregular 
margins and centric locations (8). Because of the overlap 
between the imaging fi  ndings of PDAC and other pancreatic 
cystic lesions, there is still exists a challenge in accurately 
characterizing lesions, and misdiagnoses still occur from 
time to time (3, 4).
In our study, although no specifi  c CT features were 
observed in PDAC, some characteristics of image fi  nding 
could also be useful for the differentiation. The typical SCN 
appearance as a multilocular cystic tumor consisting of 
innumerable small cysts fi  lled with clear fl  uid and separated 
by radiating and interlacing connective tissue of variable 
thickness produces a honeycomb appearance in our study, 
which is also found in previous studies (18, 19). SCN could 
be differentiated from PDAC by the characteristics of the 
mural nodes, localized thickening of the wall, irregular 
contour, and a vascular invasion. However, it is still diffi  cult 
to differentiate PDAC with intratumoral cystic degeneration 
(Fig. 3). Clinical history may be helpful. For PDAC and MCN, 
though they share many features in common such as focal 
thickening of the wall, heterogeneous content, and mural 
nodules, there still are some features that are useful for 
differentiation. For instance, MCN occurred more frequently 
in the body and tail of the pancreas while the location of 
PDAC was non-specifi  c in our study , which is similar to 
other reports (12). Besides, the image fi  ndings of multiple 
cysts, irregular contour, and the dilatation of the main 
pancreatic duct for PDAC were all different from those of 
MCN.
The recognition of a pancreatic pseudocyst resulting 
from chronic pancreatitis is usually easy when there 
are associated stigmata of chronic pancreatitis such 
as parenchymal calcifi  cations or ductal stones, ductal 
dilatation, and atrophy of the parenchyma. However, 
without these fi  ndings, pseudocysts will be a little diffi  cult 
to distinguish from PDAC (Figs. 2, 4). In addition, a history 
of prior pancreatitis is not always available in cases of 
proven pseudocyst. At imaging evaluation of PDAC in our 
study, a number of fi  ndings had been found to be useful 
for differentiating. The PDAC cases in our study usually 
appeared as irregular and multiple, as well as different from 
pseudocysts which are for the most part round or ovoid 
and unilocular. Moreover, the fi  ndings of mural nodes and 
localized thickening of the wall occurred more frequently in 
PDAC than those of pseudocysts.
Although cystic neoplasms such as a solid pseudopapillary 
tumor or mucinous cystadenocarcinoma also may contain 
enhancing soft tissue and cystic components, the infi  ltrative 
pattern of the primary tumor in ductal adenocarcinoma 
facilitates diagnosis, especially when that pattern is 
combined with ductal obstruction and vascular invasion-all 
features that are well depicted at MR imaging (2).
Fig. 3. Transverse CT scan obtained during portal venous phase 
in 46-year-old woman with pancreatic ductal adenocarcinoma 
with cystic degeneration. Image shows lobulated cystic lesion 
(arrow) in head of pancreas, which was surrounded by thin 
nonenhancing wall. 
Fig. 4. Transverse CT scan obtained during portal venous phase 
in 47-year-old woman with pancreatic ductal adenocarcinoma 
with retention cysts. Image shows solid tissue surrounded (short 
arrow) by lobulated cystic lesion (long arrow) in tail of pancreas. Solid 
tissue component was easily mistaken for normal pancreatic tissue.Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 194
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Apart from the intrinsic limits of any retrospective 
study, several other limitations should be emphasized. 
First, if we had relied on the objective region of interest 
determinations rather than on the subjective visual 
assessment of wall enhancement, we might have improved 
the validity of our results. Considering the variety of this 
lesion, our evaluation must rely only on hard-copy fi  lm 
images. Second, we included the common benign and 
malignant potential cystic lesions as the characteristics 
for differentiation of PDAC, but we did not include lesions 
such as IPMN, solid pseudopapillary tumors, and so on. The 
typical location (uncinate process), appearance (grapelike 
locular appearance), and communication with the duct at 
endoscopic retrograde cholangiopancreatography (ERCP) 
usually separates IPMN from other lesions in the pancreas. 
In addition, this entity and other pancreatic solid tumors 
with cystic features all require surgical resections and the 
preoperative clinical value is not high. Third, some of the 
cystic lesions in our series were not resected, but instead, 
the diagnosis was established by analyzing a combination 
of biochemical markers, tumor markers, and cytological 
fi  ndings. Meanwhile, we missed some lesions which did 
not accept surgical resections or biopsies. This will affect 
our study sample. Fourth, different imaging protocols and 
equipments were used during this period. However, the 
number of patients that accepted the conventional scanning 
accounted for only about 35% of the whole sample and 
might not affect the study results. Lastly, it could be argued 
that our study population is small and a more extensive 
study would be necessary to validate the outcome of this 
study.
In conclusion, our study results show that certain fi  ndings 
of PDAC: irregular contour, multiple cysts, mural nodes, 
localized thickening, as well as the dilatation of the main 
pancreatic duct, peripancreatic fat infi  ltration, and vascular 
or peripheral tissues involvement, though not specifi  c, may 
be helpful for differention. In addition, the results indicate 
that PDAC should be included in the differential diagnosis 
of pancreatic cystic neoplasms.
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